COPT Defense Properties (CDP) remains a strong buy for value and income investors, backed by essential Defense/IT assets and high tenant retention. The company has achieved 24 consecutive quarters of year-over-year FFO/share growth, with Q2 2026 FFO/share up 4.4% and same-property cash NOI increasing 7.4%. Its Redstone Gateway development is nearly fully leased and benefits from long-term U.S. defense spending. CDP's valuation at 13.4x forward P/FFO and a 3.4% yield is attractive given its consistent performance and conservative balance sheet, making it a solid choice for investors seeking dependable income and growth.
Alumis' stock dropped 56.58% after its Phase II lupus drug trial failed to meet main goals, causing a significant market reaction. However, positive results in a subgroup of lupus patients with a high interferon gene signature offer a potential path ...
SPAC stocks like Rising Dragon Acquisition surged nearly 47% amid volatility, while biotech firm bioAffinity Technologies jumped 44% after a reverse stock split. Renewable energy company Fervo Energy gained 28% following a major geothermal power deal...
Alumis Inc. shares dropped 56.76% after its Phase 2b trial for a lupus drug failed to meet key goals, though some patient groups showed promise. Enovis Corporation shares fell 16.51% following its announcement to acquire eCential Robotics for €155 mi...
Vault Strategic Mining Corp has updated the terms of its non-brokered private placement, now offering up to 12 million units at $0.125 each, aiming to raise $1.5 million. Each unit includes one common share and one warrant exercisable at $0.20 within...
Enovis has lowered its price target to $27 from $30 following its binding offer to acquire eCential Robotics for €155 million. This acquisition aims to strengthen Enovis's position in surgical robotics and enhance its ASTRA technology ecosystem. Desp...
